retatrutide and glucagon Here's an overview of based on current research 👇 1. Significant weight loss 2. Works on multiple pathways (triple-hormone action) Targets GLP-1, GIP, receptors This means it can: Reduce Retatrutide for Weight Loss: What

GLP-1 patches remain investigational, though some research shows promise for weight management and blood sugar control

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party telehealth prescribers to get their hands on these medications, a new sur | As the use of GLP-1 weight loss medications continues to grow, primary care physicians are concerned about the risks of patients using third-party telehealth prescribers to get their hands on these drugs, a new survey found.

Not only have the molecules remained on the market, utilization is increasing, suggesting that some pharmacies may be leveraging formulation additives or alternative delivery mechanisms to justify continued production

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

Help patients overcome barriers to GLP-1 therapy and weight loss surgery with transparent, empathetic cost conversations and flexible financing options.

Lose 1020% body weight with GLP-1 medications like semaglutide (Ozempic) and tirzepatide (Mounjaro)